Novavax Shares Surge 7% As It Begins Late-Stage COVID-19 Vaccine Trials
September 24, 2020 at 22:23 PM EDT
Novavax, Inc (NASDAQ: NVAX) said Thursday it was launching a large-scale diverse Phase 3 study of its COVID-19 vaccine in the United ...
